Civil Complaint Filed Against Maplewood Dentist For Illegally Prescribing Opioids In Violation Of The Controlled Substances Act
Allegations include issuing prescriptions without legitimate medical need and widespread recordkeeping violations
United States Attorney Erica H. MacDonald today announced the filing of a civil complaint against Maplewood dentist DR. JERRY KENT BRUNSOMAN and his clinic INSTITUTE OF FACIAL SURGERY ST. PAUL, PLLC, d/b/a/ IDEALSKIN LASER REJUVENATION CENTER for allegedly issuing illegitimate prescriptions for opioid medications and repeatedly failing to comply with the recordkeeping requirements of the Controlled Substances Act.
United States Attorney Erica MacDonald said, “Medical professionals have an obligation to maintain accurate and complete records of their prescribing practices, particularly when it comes to highly addictive controlled substances. My office and our DEA partners will use all available tools to address the devastating opioid epidemic.”
In the complaint filed today, the United States alleges that BRUNSOMAN unlawfully issued multiple prescriptions for Schedule II controlled substances, namely, oxycodone and hydrocodone, without a legitimate medical purpose. The complaint further alleges that BRUNSOMAN failed to keep complete and accurate records regarding the receipt and dispensing of controlled substances used at his clinic. As a licensed practitioner, BRUNSOMAN must comply with the Controlled Substances Act’s recordkeeping and prescribing requirements, which Congress enacted to prevent the diversion of controlled substances for illegal purposes. As a result of BRUNSOMAN’S alleged actions, hundreds of doses of controlled substances are unaccounted for and presumed to have been diverted for illicit purposes.
The United States is seeking civil monetary penalties and injunctive relief for the defendants’ alleged violations of the Controlled Substances Act.
This case is handled by the Affirmative Civil Enforcement unit of the U.S. Attorney’s Office for the District of Minnesota, and was investigated by the Diversion Group of the Drug Enforcement Administration, Minneapolis-St. Paul District Office.
The civil complaint presents allegations only; there has been no determination of liability or wrongdoing.
Additional news available on our website.
United States Attorney’s Office, District of Minnesota: (612) 664-5600